APA(7版)引用形式

Trenas-Calero, A., Prieto-Laín, N., Pérez-Velasco, M. A., Padilla-Leiva, C., Pérez-Ruiz, J. M., Ruíz-Rodríguez, F. I., . . . Pérez-Belmonte, L. M. (2026, June). Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis. Pharmaceuticals.

Chicagoスタイル(17版)引用形式

Trenas-Calero, Alicia, Nuria Prieto-Laín, Miguel A. Pérez-Velasco, Claudia Padilla-Leiva, José M. Pérez-Ruiz, Fátima I. Ruíz-Rodríguez, Ricardo Gómez-Huelgas, María-Rosa Bernal-López, , Luis M. Pérez-Belmonte. "Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis." Pharmaceuticals Jun. 2026.

MLA(9版)引用形式

Trenas-Calero, Alicia, et al. "Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis." Pharmaceuticals, Jun. 2026.

警告: この引用は必ずしも正確ではありません.